Nerve growth factor level may be marker for neurogenic overactive bladder, interstitial cystitis

Nerve growth factor (NGF) levels in urine could prove a useful biomarker for interstitial cystitis/painful bladder syndrome (IC/PBS) and neurogenic overactive bladder.

Related Videos

Related Content

Advertisement

January 29th 2025

FDA market clearance sought for Separo sealing system for vasectomy

Matthew J. Mutter, MD

"The biggest thing that I took away from using the device is that it allowed me to do the procedure by myself, without an assistant," says Matthew J. Mutter, MD.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 28th 2025

Key FDA decisions urologists can expect in the first half of 2025

Hannah Clarke

Check out the key regulatory decisions set to happen early this year.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 27th 2025

Black men cite lack of invitation, information as key barriers to prostate cancer trials

Hannah Clarke

According to the authors, these findings highlight the need to more effectively include Black men in prostate cancer research.

January 27th 2025

Anktiva under review in EU for BCG-unresponsive NMIBC with CIS

Hannah Clarke

If approved, the marketing authorization application would be valid in all 27 European Union member states as well as in Iceland, Liechtenstein, and Norway.

Related Content

Advertisement

January 29th 2025

FDA market clearance sought for Separo sealing system for vasectomy

Matthew J. Mutter, MD

"The biggest thing that I took away from using the device is that it allowed me to do the procedure by myself, without an assistant," says Matthew J. Mutter, MD.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 28th 2025

Key FDA decisions urologists can expect in the first half of 2025

Hannah Clarke

Check out the key regulatory decisions set to happen early this year.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 27th 2025

Black men cite lack of invitation, information as key barriers to prostate cancer trials

Hannah Clarke

According to the authors, these findings highlight the need to more effectively include Black men in prostate cancer research.

January 27th 2025

Anktiva under review in EU for BCG-unresponsive NMIBC with CIS

Hannah Clarke

If approved, the marketing authorization application would be valid in all 27 European Union member states as well as in Iceland, Liechtenstein, and Norway.